Cargando…
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500253/ https://www.ncbi.nlm.nih.gov/pubmed/34625750 http://dx.doi.org/10.1038/s41591-021-01569-2 |
| _version_ | 1784580413545512960 |
|---|---|
| author | Kyriazopoulou, Evdoxia Poulakou, Garyfallia Milionis, Haralampos Metallidis, Simeon Adamis, Georgios Tsiakos, Konstantinos Fragkou, Archontoula Rapti, Aggeliki Damoulari, Christina Fantoni, Massimo Kalomenidis, Ioannis Chrysos, Georgios Angheben, Andrea Kainis, Ilias Alexiou, Zoi Castelli, Francesco Serino, Francesco Saverio Tsilika, Maria Bakakos, Petros Nicastri, Emanuele Tzavara, Vassiliki Kostis, Evangelos Dagna, Lorenzo Koufargyris, Panagiotis Dimakou, Katerina Savvanis, Spyridon Tzatzagou, Glykeria Chini, Maria Cavalli, Giulio Bassetti, Matteo Katrini, Konstantina Kotsis, Vasileios Tsoukalas, George Selmi, Carlo Bliziotis, Ioannis Samarkos, Michael Doumas, Michael Ktena, Sofia Masgala, Aikaterini Papanikolaou, Ilias Kosmidou, Maria Myrodia, Dimitra-Melia Argyraki, Aikaterini Cardellino, Chiara Simona Koliakou, Katerina Katsigianni, Eleni-Ioanna Rapti, Vassiliki Giannitsioti, Efthymia Cingolani, Antonella Micha, Styliani Akinosoglou, Karolina Liatsis-Douvitsas, Orestis Symbardi, Styliani Gatselis, Nikolaos Mouktaroudi, Maria Ippolito, Giuseppe Florou, Eleni Kotsaki, Antigone Netea, Mihai G. Eugen-Olsen, Jesper Kyprianou, Miltiades Panagopoulos, Periklis Dalekos, George N. Giamarellos-Bourboulis, Evangelos J. |
| author_facet | Kyriazopoulou, Evdoxia Poulakou, Garyfallia Milionis, Haralampos Metallidis, Simeon Adamis, Georgios Tsiakos, Konstantinos Fragkou, Archontoula Rapti, Aggeliki Damoulari, Christina Fantoni, Massimo Kalomenidis, Ioannis Chrysos, Georgios Angheben, Andrea Kainis, Ilias Alexiou, Zoi Castelli, Francesco Serino, Francesco Saverio Tsilika, Maria Bakakos, Petros Nicastri, Emanuele Tzavara, Vassiliki Kostis, Evangelos Dagna, Lorenzo Koufargyris, Panagiotis Dimakou, Katerina Savvanis, Spyridon Tzatzagou, Glykeria Chini, Maria Cavalli, Giulio Bassetti, Matteo Katrini, Konstantina Kotsis, Vasileios Tsoukalas, George Selmi, Carlo Bliziotis, Ioannis Samarkos, Michael Doumas, Michael Ktena, Sofia Masgala, Aikaterini Papanikolaou, Ilias Kosmidou, Maria Myrodia, Dimitra-Melia Argyraki, Aikaterini Cardellino, Chiara Simona Koliakou, Katerina Katsigianni, Eleni-Ioanna Rapti, Vassiliki Giannitsioti, Efthymia Cingolani, Antonella Micha, Styliani Akinosoglou, Karolina Liatsis-Douvitsas, Orestis Symbardi, Styliani Gatselis, Nikolaos Mouktaroudi, Maria Ippolito, Giuseppe Florou, Eleni Kotsaki, Antigone Netea, Mihai G. Eugen-Olsen, Jesper Kyprianou, Miltiades Panagopoulos, Periklis Dalekos, George N. Giamarellos-Bourboulis, Evangelos J. |
| author_sort | Kyriazopoulou, Evdoxia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8500253 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85002532021-10-08 Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial Kyriazopoulou, Evdoxia Poulakou, Garyfallia Milionis, Haralampos Metallidis, Simeon Adamis, Georgios Tsiakos, Konstantinos Fragkou, Archontoula Rapti, Aggeliki Damoulari, Christina Fantoni, Massimo Kalomenidis, Ioannis Chrysos, Georgios Angheben, Andrea Kainis, Ilias Alexiou, Zoi Castelli, Francesco Serino, Francesco Saverio Tsilika, Maria Bakakos, Petros Nicastri, Emanuele Tzavara, Vassiliki Kostis, Evangelos Dagna, Lorenzo Koufargyris, Panagiotis Dimakou, Katerina Savvanis, Spyridon Tzatzagou, Glykeria Chini, Maria Cavalli, Giulio Bassetti, Matteo Katrini, Konstantina Kotsis, Vasileios Tsoukalas, George Selmi, Carlo Bliziotis, Ioannis Samarkos, Michael Doumas, Michael Ktena, Sofia Masgala, Aikaterini Papanikolaou, Ilias Kosmidou, Maria Myrodia, Dimitra-Melia Argyraki, Aikaterini Cardellino, Chiara Simona Koliakou, Katerina Katsigianni, Eleni-Ioanna Rapti, Vassiliki Giannitsioti, Efthymia Cingolani, Antonella Micha, Styliani Akinosoglou, Karolina Liatsis-Douvitsas, Orestis Symbardi, Styliani Gatselis, Nikolaos Mouktaroudi, Maria Ippolito, Giuseppe Florou, Eleni Kotsaki, Antigone Netea, Mihai G. Eugen-Olsen, Jesper Kyprianou, Miltiades Panagopoulos, Periklis Dalekos, George N. Giamarellos-Bourboulis, Evangelos J. Nat Med Author Correction Nature Publishing Group US 2021-10-08 2021 /pmc/articles/PMC8500253/ /pubmed/34625750 http://dx.doi.org/10.1038/s41591-021-01569-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Kyriazopoulou, Evdoxia Poulakou, Garyfallia Milionis, Haralampos Metallidis, Simeon Adamis, Georgios Tsiakos, Konstantinos Fragkou, Archontoula Rapti, Aggeliki Damoulari, Christina Fantoni, Massimo Kalomenidis, Ioannis Chrysos, Georgios Angheben, Andrea Kainis, Ilias Alexiou, Zoi Castelli, Francesco Serino, Francesco Saverio Tsilika, Maria Bakakos, Petros Nicastri, Emanuele Tzavara, Vassiliki Kostis, Evangelos Dagna, Lorenzo Koufargyris, Panagiotis Dimakou, Katerina Savvanis, Spyridon Tzatzagou, Glykeria Chini, Maria Cavalli, Giulio Bassetti, Matteo Katrini, Konstantina Kotsis, Vasileios Tsoukalas, George Selmi, Carlo Bliziotis, Ioannis Samarkos, Michael Doumas, Michael Ktena, Sofia Masgala, Aikaterini Papanikolaou, Ilias Kosmidou, Maria Myrodia, Dimitra-Melia Argyraki, Aikaterini Cardellino, Chiara Simona Koliakou, Katerina Katsigianni, Eleni-Ioanna Rapti, Vassiliki Giannitsioti, Efthymia Cingolani, Antonella Micha, Styliani Akinosoglou, Karolina Liatsis-Douvitsas, Orestis Symbardi, Styliani Gatselis, Nikolaos Mouktaroudi, Maria Ippolito, Giuseppe Florou, Eleni Kotsaki, Antigone Netea, Mihai G. Eugen-Olsen, Jesper Kyprianou, Miltiades Panagopoulos, Periklis Dalekos, George N. Giamarellos-Bourboulis, Evangelos J. Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial |
| title | Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial |
| title_full | Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial |
| title_fullStr | Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial |
| title_full_unstemmed | Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial |
| title_short | Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial |
| title_sort | author correction: early treatment of covid-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500253/ https://www.ncbi.nlm.nih.gov/pubmed/34625750 http://dx.doi.org/10.1038/s41591-021-01569-2 |
| work_keys_str_mv | AT kyriazopoulouevdoxia authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT poulakougaryfallia authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT milionisharalampos authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT metallidissimeon authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT adamisgeorgios authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT tsiakoskonstantinos authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT fragkouarchontoula authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT raptiaggeliki authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT damoularichristina authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT fantonimassimo authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT kalomenidisioannis authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT chrysosgeorgios authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT anghebenandrea authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT kainisilias authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT alexiouzoi authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT castellifrancesco authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT serinofrancescosaverio authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT tsilikamaria authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT bakakospetros authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT nicastriemanuele authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT tzavaravassiliki authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT kostisevangelos authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT dagnalorenzo authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT koufargyrispanagiotis authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT dimakoukaterina authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT savvanisspyridon authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT tzatzagouglykeria authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT chinimaria authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT cavalligiulio authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT bassettimatteo authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT katrinikonstantina authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT kotsisvasileios authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT tsoukalasgeorge authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT selmicarlo authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT bliziotisioannis authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT samarkosmichael authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT doumasmichael authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT ktenasofia authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT masgalaaikaterini authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT papanikolaouilias authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT kosmidoumaria authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT myrodiadimitramelia authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT argyrakiaikaterini authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT cardellinochiarasimona authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT koliakoukaterina authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT katsigiannieleniioanna authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT raptivassiliki authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT giannitsiotiefthymia authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT cingolaniantonella authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT michastyliani authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT akinosogloukarolina authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT liatsisdouvitsasorestis authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT symbardistyliani authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT gatselisnikolaos authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT mouktaroudimaria authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT ippolitogiuseppe authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT floroueleni authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT kotsakiantigone authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT neteamihaig authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT eugenolsenjesper authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT kyprianoumiltiades authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT panagopoulosperiklis authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT dalekosgeorgen authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial AT giamarellosbourboulisevangelosj authorcorrectionearlytreatmentofcovid19withanakinraguidedbysolubleurokinaseplasminogenreceptorplasmalevelsadoubleblindrandomizedcontrolledphase3trial |